Loading insider details...
Latest Form 4 (Aug 12, 2026): Grant/Award of 102,400 MLYS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 102,400 | n/a |
| Feb 6, 2025 | Cadrenal Therapeutics, Inc. (CVKD) | Grant/Award | 60,000 | n/a |
| Dec 15, 2023 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 1,200,000 | n/a |
| Dec 22, 2022 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 625,000 | n/a |
| Dec 15, 2021 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 587,600 | n/a |
| Jan 4, 2021 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 575,000 | n/a |
| Jun 19, 2020 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 250,000 | n/a |
| Jan 3, 2020 | Matinas BioPharma Holdings, Inc. (MTNB) | Grant/Award | 500,000 | n/a |